Ajanta Pharma reports 76% surge in Q3 net profit

23 Jan 2013 Evaluate

Ajanta Pharma has reported results for third quarter ended December 31, 2012.

The company has registered a rise of 75.96% in its net profit at Rs 32.57 crore in Q3FY13 as compared to Rs 18.51 crore in the corresponding quarter previous year. The total income from operation of the company has increased by 39.65% to Rs 229.34 crore for the quarter under review as compared to Rs 164.23 crore in the same quarter last year.

Ajanta Pharma (APL) is engaged manufacturing pharmaceutical products. The company runs three divisions -- prescription drugs, OTC and institutional sales.

Ajanta Pharma Share Price

2638.75 12.50 (0.48%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×